|
|
|
Volumn 5, Issue 11, 2006, Pages 1425-1428
|
|
FDA approves Avastin in combination with chemotherapy for first-line treatment of most common type of lung cancer.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
VASCULOTROPIN A;
ARTICLE;
DRUG COMBINATION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LUNG TUMOR;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
DRUG THERAPY, COMBINATION;
HUMANS;
LUNG NEOPLASMS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 34249933543
PISSN: 15384047
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|